Cambridge Nutritional Sciences Plc
(LSE) CNSL
Cambridge Nutritional Sciences Plc Financials at a Glance
Market Cap
$440.21M
Revenue (TTM)
$17.03M
Net Income (TTM)
$1.54M
EPS (TTM)
$0.57
P/E Ratio
3.25
Dividend
$0.00
Beta (Volatility)
0.15 (Low)
Dividend
$0.00
Beta (Volatility)
0.15 (Low)
Price
$0.02
Volume
819,417
Open
$1.76
Price
$0.02
Volume
819,417
Open
$1.76
Previous Close
$1.87
Daily Range
$1.76 - $1.90
52-Week Range
$1.70 - $4.33
Dividend
$0.00
Beta (Volatility)
0.15 (Low)
Price
$0.02
Volume
819,417
Open
$1.76
Previous Close
$1.87
Daily Range
$1.76 - $1.90
52-Week Range
$1.70 - $4.33
CNSL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cambridge Nutritional Sciences Plc
Industry
Healthcare Equipment and Supplies
Sector
Health CareCEO
James Cooper
Website
www.omegadiagnostics.comHeadquarters
London, EC4M 7WS, GB
CNSL Financials
Key Financial Metrics (TTM)
Gross Margin
61%
Operating Margin
-11%
Net Income Margin
17%
Return on Equity
13%
Return on Capital
-8%
Return on Assets
11%
Earnings Yield
30.77%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$440.21M
Shares Outstanding
237.95M
Volume
819.42K
Short Interest
0.00%
Avg. Volume
201.07K
Financials (TTM)
Gross Profit
$5.00M
Operating Income
$640.00K
EBITDA
$2.20M
Operating Cash Flow
$83.00K
Capital Expenditure
$225.00K
Free Cash Flow
$142.00K
Cash & ST Invst.
$4.87M
Total Debt
$349.00K
Cambridge Nutritional Sciences Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.86M
-21.7%
Gross Profit
$2.39M
-16.9%
Gross Margin
61.84%
N/A
Market Cap
$440.21M
N/A
Market Cap/Employee
$4.68M
N/A
Employees
94
N/A
Net Income
$397.00K
+43.1%
EBITDA
$66.00K
+81.6%
Quarterly Fundamentals
Net Cash
$3.36M
-19.7%
Accounts Receivable
$2.31M
+0.9%
Inventory
$729.00K
-32.1%
Long Term Debt
$75.00K
-6.3%
Short Term Debt
$162.00K
+20.9%
Return on Assets
10.76%
N/A
Return on Invested Capital
-8.00%
N/A
Free Cash Flow
$917.00K
-55.7%
Operating Cash Flow
$734.00K
-26.8%